Subscribe

Main navigation

Home
Conferences
2026 Washington, DC
2026 London
2025 Berlin
2024 Athens
2023 New York City
CME
Spotlight
Studies
Media
About
About SEGM
FAQ
Our Response to the SPLC
Contact
Support

Search results

Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents

February 1, 2017
Studies

SEGM Summary:

In healthy adolescents, bone mass accumulates during puberty. The first retrospective study of the effects of suppressing puberty and cross-sex hormones on bone turnover markers in 56 adolescents with gender dysphoria examined the effects of pubertal suppression by...

Transgender Vascular Health: Interactions Between Gender Identity, Hormone Therapy, and Vascular Disease Risk

June 1, 2026
Studies
Transgender individuals face unique challenges in vascular health due to the complex interactions between gender identity, psychosocial determinants of health, and medical interventions such as gender-affirming hormone therapy (GAHT). Growing evidence indicates that transgender populations may...
Matched fragments:
… estrogens, anti-androgens, and testosterone, may influence …

Heart rate variability in transgender people receiving Gender-Affirming hormone therapy

February 16, 2026
Studies
Background Gender-affirming hormone therapy has shown benefits in alleviating gender-related distress and enhancing overall well-being. However, its effects on cardiovascular health are not yet fully understood. Purpose To evaluate heart rate variability, a preclinical marker of cardiovascular...
Matched fragments:
… These findings suggest that testosterone therapy may impair …

Desire for children and fertility preservation in transgender and gender-diverse people: A systematic review

March 1, 2023
Studies
The decision to pursue one's desire for children is a basic human right. For transgender and gender-diverse (TGD) people, gender-affirming care may alter the possibilities to fulfill one's desire for children due to the impact of this treatment on their reproductive organs. We systematically...
Matched fragments:
… successful outcomes, even after testosterone cessation. Sperm …

Psychosocial functioning in transgender youth after 2 years of hormones

January 19, 2023
Studies
Background Limited prospective outcome data exist regarding transgender and nonbinary youth receiving gender-affirming hormones (GAH; testosterone or estradiol). Methods We characterized the longitudinal course of psychosocial functioning during the 2 years after GAH initiation in a prospective...
Matched fragments:
… gender-affirming hormones (GAH; testosterone or estradiol). Methods …

Impact of gender-affirming treatment on bone health in transgender and gender diverse youth

November 1, 2022
Studies
Both in the United States and Europe, the number of minors who present at transgender healthcare services before the onset of puberty is rapidly expanding. Many of those who will have persistent gender dysphoria at the onset of puberty will pursue long-term puberty suppression before reaching the...
Matched fragments:
… re-evaluation after estradiol or testosterone administration. Results …

Adherence to Gender Affirming Hormone Therapy in Transgender Adolescents and Adults: A Retrospective Cohort Study

May 29, 2023
Studies
Context Transgender and gender diverse (TGD) individuals often seek gender affirming hormone therapy (GAHT). While receipt of GAHT has been associated with improved well-being, the risk of GAHT discontinuation and its reasons are not well known. Objectives 1) To investigate proportion...
Matched fragments:
… prescribed estradiol or testosterone between 01/01/2000- …

Gender dysphoria in young people is rising—and so is professional disagreement

February 23, 2023
Studies
Last October the American Academy of Pediatrics (AAP) gathered inside the Anaheim Convention Center in California for its annual conference. Outside, several dozen people rallied to hear speakers including Abigail Martinez, a mother whose child began hormone treatment at age 16 and died by suicide...
Matched fragments:
… to suppress puberty; oestrogen or testosterone to promote secondary …

Immune dynamics throughout life in relation to sex hormones and perspectives gained from gender-affirming hormone therapy

January 16, 2025
Studies
Biological sex is closely associated with the properties and extent of the immune response, with males and females showing different susceptibilities to diseases and variations in immunity. Androgens, predominantly in males, generally suppress immune responses, while estrogens, more abundant in...
Matched fragments:
… research has revealed that testosterone therapy in transgender …

Bone Health in the Transgender Population

June 1, 2019
Studies
It is well known that sex steroids, particularly estrogen, play a crucial role in the attainment and maintenance of peak bone density in all people. Transgender (trans) have been frequently observed to have low bone density prior to initiation of gender-affirming hormone therapy, while trans men...
Matched fragments:
… trans women. With pharmacologic testosterone, bone density in trans …

Pagination

  • First page « First
  • Previous page ‹
  • …
  • Page 4
  • Page 5
  • Current page 6
  • Page 7
  • Page 8
  • Next page ›
  • Last page Last »

SEGM is committed to safeguarding scientific integrity through open discourse and collaboration. Researchers and clinicians worldwide must be free to pursue scientific inquiry without censorship or intimidation.

Our Response to the SPLC
FAQs about SEGM
Close

Society for Evidence-Based Gender Medicine

© 2020-2026 SEGM